MENAT 注射器市场预测至 2028 年 - COVID-19 影响和按注射器类型（鲁尔锁注射器、玻璃注射器、鲁尔滑动注射器等）、应用（美学、人类健康、实验室/工业等）、可用性进行的区域分析（可消毒/可重复使用注射器和一次性注射器）和最终用户（医院和诊所、采血中心、糖尿病护理中心等）
No. of Pages: 206 | Report Code: BMIRE00027652 | Category: Life Sciences
No. of Pages: 206 | Report Code: BMIRE00027652 | Category: Life Sciences
市场增长主要归因于慢性病和传染病患病率上升等因素疾病和越来越多地采用注射药物。然而，针刺伤或锐器伤 (NSI) 病例的增加可能会阻碍市场增长。
MENAT 注射器市场分为沙特阿拉伯、南非、阿联酋、土耳其、埃及、摩洛哥和 MENAT 的其他地区。由于非传染性疾病和传染性疾病的患病率不断上升，沙特阿拉伯和南非预计将成为 MENAT 注射器市场的主要贡献者。
越来越多的人采用注射药物
肠外注射提供药物剂量的可靠性和精确性，以及药物作用的快速起效。注射给药装置，例如传统注射器、无针注射器以及自动注射器和笔式注射器，广泛用于给药以治疗从癌症到自身免疫性疾病等疾病。生物制剂的给药主要通过注射途径完成。制药公司已开始在 MENAT 地区生产生物制剂。例如，2021年11月，默克宣布将帮助沙特阿拉伯的SaudiVax设计和建造一座多模式生物制剂制造设施，作为该国为中东和北非地区提供更加本地化的生产基础设施的一部分。此外，2020 年 12 月，SaudiVax Ltd. 与强生公司签署了谅解备忘录 (MoU)。 Johnson Middle East FZ LLC 致力于顶级生物药品的本地化生产。因此，SaudiVax 成为强生公司的制造合作伙伴。沙特阿拉伯的强生公司本地生产最高质量的药品。
对疫苗、胰岛素、人类生长激素和许多治疗癌症的现代药物的需求不断增长和其他慢性疾病。根据 BioPharm International 的数据，生物制剂目前约占全球销量前 10 名药物的 70%。因此，注射药物的日益普及需要增加注射器的使用，这推动了市场增长。
基于注射器类型的见解
根据注射器类型，MENAT 注射器市场分为鲁尔锁注射器、玻璃注射器、鲁尔滑动注射器等。 2021 年，鲁尔锁注射器细分市场占据最大市场份额。玻璃注射器领域预计在未来几年增长最快。
基于应用程序的见解
根据应用，MENAT 注射器市场分为美学、人类健康、实验室/工业等。 2021年，人类健康领域占据最大的市场份额。预计美学领域在未来几年将以最快的速度增长。
基于可用性的见解
基于最终用户的见解
< /p>
根据最终用户，MENAT 注射器市场分为医院和医院。诊所、采血中心、糖尿病护理中心等。 2021 年，医院和医院诊所部门占据了最大的市场份额。糖尿病护理中心领域预计在未来几年将以最快的速度增长。
世界卫生组织 (WHO)、美国卫生与公众服务部、关节炎基金会、世界心脏联合会、美国糖尿病协会、卫生部 –阿布扎比、国际糖尿病联合会 (IDF) 和国家医学图书馆 (NLM) 是在准备 MENAT 注射器市场报告时参考的主要一手和二手资料来源。
Strategic insights for MENAT Syringe involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 882.66 Million |
| Market Size by 2028 | US$ 1,570.79 Million |
| Global CAGR (2022 - 2028) | 8.6% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 注射器类型
|
| Regions and Countries Covered | 中东和北非
|
| Market leaders and key company profiles |
The regional scope of MENAT Syringe refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The MENAT Syringe Market is valued at US$ 882.66 Million in 2021, it is projected to reach US$ 1,570.79 Million by 2028.
As per our report MENAT Syringe Market, the market size is valued at US$ 882.66 Million in 2021, projecting it to reach US$ 1,570.79 Million by 2028. This translates to a CAGR of approximately 8.6% during the forecast period.
The MENAT Syringe Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the MENAT Syringe Market report:
The MENAT Syringe Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The MENAT Syringe Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the MENAT Syringe Market value chain can benefit from the information contained in a comprehensive market report.
E 1803, Panchshil Towers, Vagholi, Haveli, Pune- 412207, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For MENAT Syringe Market
